Martin F. Bachmann

Bern, BE 3010, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development.

Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development.

Journal: NPJ vaccines
Published: February 29, 2024

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.

Journal: Vaccines
Published: May 03, 2019

Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine Design.

Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine Design.

Journal: Vaccines
Published: May 02, 2019

Immunogenicity and Immunodominance in Antibody Responses.

Immunogenicity and Immunodominance in Antibody Responses.

Journal: Current topics in microbiology and immunology
Published: March 29, 2019

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.

Journal: Diseases (Basel, Switzerland)
Published: September 28, 2018

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.

Journal: Vaccines
Published: February 24, 2017

Active immunotherapy for chronic diseases.

Active immunotherapy for chronic diseases.

Journal: Vaccine
Published: October 10, 2012

Taurine: energy drink for T cells.

Taurine: energy drink for T cells.

Journal: European journal of immunology
Published: April 26, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026